RO86661A - PROCEDURE FOR OBTAINING A GLOBULINE PREPARATION IMMUNE TO TUMORS - Google Patents

PROCEDURE FOR OBTAINING A GLOBULINE PREPARATION IMMUNE TO TUMORS

Info

Publication number
RO86661A
RO86661A RO83110576A RO11057683A RO86661A RO 86661 A RO86661 A RO 86661A RO 83110576 A RO83110576 A RO 83110576A RO 11057683 A RO11057683 A RO 11057683A RO 86661 A RO86661 A RO 86661A
Authority
RO
Romania
Prior art keywords
globuline
tumors
procedure
obtaining
preparation immune
Prior art date
Application number
RO83110576A
Other languages
French (fr)
Romanian (ro)
Other versions
RO86661B (en
Inventor
David S Terman
Original Assignee
Baylor College Of Medicine,Us
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College Of Medicine,Us filed Critical Baylor College Of Medicine,Us
Publication of RO86661B publication Critical patent/RO86661B/en
Publication of RO86661A publication Critical patent/RO86661A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6851—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RO83110576A 1982-04-07 1983-04-06 PROCEDURE FOR OBTAINING A GLOBULINE PREPARATION IMMUNE TO TUMORS RO86661A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36643682A 1982-04-07 1982-04-07
US36613682A 1982-04-07 1982-04-07
US47236283A 1983-03-11 1983-03-11

Publications (2)

Publication Number Publication Date
RO86661B RO86661B (en) 1985-03-01
RO86661A true RO86661A (en) 1986-07-30

Family

ID=27003359

Family Applications (3)

Application Number Title Priority Date Filing Date
RO83114843A RO89498A (en) 1982-04-07 1983-04-06 PROCEDURE FOR OBTAINING A PRODUCT WITH ANTITUMORAL ACTIVITY
RO83110576A RO86661A (en) 1982-04-07 1983-04-06 PROCEDURE FOR OBTAINING A GLOBULINE PREPARATION IMMUNE TO TUMORS
RO83114841A RO89496A (en) 1982-04-07 1983-04-06 PROCESS FOR OBTAINING THE ANTI-TUMOR COMPLEX PROTEIN A-IMUNOGLOBULINA

Family Applications Before (1)

Application Number Title Priority Date Filing Date
RO83114843A RO89498A (en) 1982-04-07 1983-04-06 PROCEDURE FOR OBTAINING A PRODUCT WITH ANTITUMORAL ACTIVITY

Family Applications After (1)

Application Number Title Priority Date Filing Date
RO83114841A RO89496A (en) 1982-04-07 1983-04-06 PROCESS FOR OBTAINING THE ANTI-TUMOR COMPLEX PROTEIN A-IMUNOGLOBULINA

Country Status (13)

Country Link
EP (1) EP0091784B1 (en)
AU (2) AU569467B2 (en)
CA (1) CA1230555A (en)
DE (1) DE3374756D1 (en)
DK (1) DK154283A (en)
ES (5) ES521279A0 (en)
FI (1) FI831169L (en)
GB (2) GB2119803B (en)
GR (1) GR78514B (en)
NO (5) NO831223L (en)
PT (1) PT76505B (en)
RO (3) RO89498A (en)
ZW (1) ZW7583A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2161813B (en) * 1984-07-20 1988-07-13 Michiko Koga Anti-tumor agent
GB9013872D0 (en) * 1990-06-21 1990-08-15 Inst Tecnologico Y Cientifico Use of protein a and polypeptide components thereof in the treatment of tumours
CA2160155A1 (en) * 1993-04-08 1994-10-27 Stella Nowicki Model for gonococcal infection
GB2422311A (en) * 2005-01-20 2006-07-26 Martin Lister Treatment of blood to cure disease
DE102005012594A1 (en) 2005-03-18 2006-09-21 Bayer Technology Services Gmbh Electric filtration methods
JP2012526997A (en) * 2009-05-14 2012-11-01 オートミール バイオテクノロジーズ グループ， エル．エル．シー． Platform technology for spontaneous disease
EP4353320A3 (en) * 2016-04-28 2024-05-15 Alkahest, Inc. Blood plasma and plasma fractions as therapy for tumor growth and progression

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132769A (en) * 1974-10-30 1979-01-02 Osther Kurt B Cancer antigen, cancer therapy, and cancer diagnosis
US4146603A (en) * 1977-02-18 1979-03-27 Research Corporation Tumor specific glycoproteins and method for detecting tumorigenic cancers
FI791551A (en) * 1978-05-17 1979-11-18 Benzon As Alfred RENAD CANCER ASSOCIERAD PROTEIN

Also Published As

Publication number Publication date
DK154283A (en) 1983-10-08
ES8503953A1 (en) 1985-04-16
GB8510892D0 (en) 1985-06-05
GR78514B (en) 1984-09-27
RO86661B (en) 1985-03-01
ES528119A0 (en) 1985-04-16
NO841495L (en) 1983-10-10
PT76505A (en) 1983-05-01
EP0091784A3 (en) 1984-07-11
FI831169A0 (en) 1983-04-06
NO841498L (en) 1983-10-10
PT76505B (en) 1986-05-05
RO89498A (en) 1986-06-30
FI831169L (en) 1983-10-08
ES528118A0 (en) 1985-04-16
RO89496A (en) 1986-06-30
CA1230555A (en) 1987-12-22
GB2119803A (en) 1983-11-23
NO841497L (en) 1983-10-10
GB8309348D0 (en) 1983-05-11
ES8503950A1 (en) 1985-04-16
GB2163164B (en) 1986-09-03
ES8405621A1 (en) 1984-06-16
ES528120A0 (en) 1985-04-16
ZW7583A1 (en) 1983-06-29
ES528121A0 (en) 1985-11-01
EP0091784B1 (en) 1987-12-02
DK154283D0 (en) 1983-04-07
NO841496L (en) 1983-10-10
EP0091784A2 (en) 1983-10-19
AU1560088A (en) 1988-10-27
ES8503954A1 (en) 1985-04-16
ES8601703A1 (en) 1985-11-01
GB2119803B (en) 1986-09-03
AU1286583A (en) 1983-10-13
NO831223L (en) 1983-10-10
ES521279A0 (en) 1984-06-16
AU569467B2 (en) 1988-02-04
DE3374756D1 (en) 1988-01-14
GB2163164A (en) 1986-02-19

Similar Documents

Publication Publication Date Title
NO832616L (en) PROCEDURE FOR PREPARING A DIHYDROERYTROMYCIN DERIVATE
IT8320789A0 (en) PROCEDURE FOR THE PREPARATION OF METHYLACETATE.
ES503188A0 (en) A PROCEDURE FOR THE PREPARATION OF A 1-BENZOIL-UREA 3-SUBSTITUTED
ES538020A0 (en) PROCEDURE FOR PREPARING PENICILIN DERIVATIVES
DK237283A (en) FUNGICID PREPARATION
ES525953A0 (en) PROCEDURE FOR OBTAINING PIPERAZINIC DERIVATIVES
RO86661A (en) PROCEDURE FOR OBTAINING A GLOBULINE PREPARATION IMMUNE TO TUMORS
ES524978A0 (en) PROCEDURE FOR THE PREPARATION OF QUINUCLIDINE DERIVATIVES
RO88128A (en) PROCESS FOR THE PREPARATION OF N-PHOSFANOMETILGLICINE
RO85392A (en) PROCEDURE FOR PREPARATION & HALOALCHILAMIDE
ES504418A0 (en) PROCEDURE FOR PREPARING NEW CONDENSED AS-TRIACINIC DERIVATIVES
NO833655L (en) PROCEDURE FOR PREPARING ANTIGEN
ES527054A0 (en) PROCEDURE FOR OBTAINING BIS-QUINAZOLINIC DERIVATIVES
ES524897A0 (en) PROCEDURE FOR THE PREPARATION OF NEW ANTIHELMINTIC PRODUCTS
ES524479A0 (en) INDOLINES PREPARATION PROCEDURE
ES527737A0 (en) DINUCLEOSID-MONOPHOSPHATE PREPARATION PROCEDURE
NO833128L (en) PROCEDURE FOR PREPARING SUBSTITUTED 1-PYRIDYLOXY-3-INDOLYLALKYLAMINO-2-PROPANOLS
ES522651A0 (en) PIPERACINE DERIVATIVES PREPARATION PROCEDURE
IT1172263B (en) PROCEDURE FOR THE PREPARATION OF THIO-BISPHENOLS
IT1169421B (en) PROCEDURE FOR THE PREPARATION OF BENZEN-DERIVATIVES
ES533209A0 (en) PROCEDURE FOR THE PREPARATION OF PHENOXYBENZOIC ACID DERIVATIVES
IT8347549A0 (en) PROCEDURE FOR THE PREPARATION OF SUBSTITUTED CHLOROACETANILIDS
ES551558A0 (en) PREPARATION PROCEDURE FOR 20-CETO-DELTA16-STEROIDS
IT1163477B (en) FERMENTATION PREPARATION PROCEDURE FOR L-LEUCINA
ES525995A0 (en) PROCEDURE FOR OBTAINING PIRIDOPIRIMIDINONES